CommercialCoverageMedium impact
11.11.03d, Cryosurgical Ablation of the Prostate Gland
Independence Blue Cross·Urology·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
The policy for Cryosurgical Ablation of the Prostate Gland (11.11.03d) has been reissued and will take effect April 2, 2025. This is an updated commercial policy that may contain changes to coverage criteria, billing requirements, or documentation standards for prostate cryosurgery procedures.
Action Required
By April 2, 2025: Billing team must review the updated policy 11.11.03d for Cryosurgical Ablation of the Prostate Gland at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or documentation standards. Update billing procedures and provider workflows accordingly for commercial plans.